Clinical Trials Directory

Trials / Completed

CompletedNCT01263626

Cough Monitoring Study

Monitoring Cough Device - Step 1 and 2

Status
Completed
Phase
Study type
Observational
Enrollment
33 (actual)
Sponsor
Vanderbilt University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to establish the accuracy of a new device designed specifically to record and detect cough episodes. Cough is an important defense mechanism of the respiratory tract. The presence of chronic cough may indicate the presence of underlying diseases, including reflux. Despite the increased number of patients suffering from cough in the ENT and GI practice, to date, there has been no method/device to objectively assess the frequency of cough episodes in a given patient. PULMOTRACK-CC, manufactured by KarmelSonix (Haifa, Israel), has recently introduced an innovative device that is able to record cough episodes and then automatically detect and count them with the help of a specific software program. This study will assess the accuracy of this novel cough monitoring and counting technology and validate potential clinical use in patients with chronic cough.

Conditions

Timeline

Start date
2010-11-01
Primary completion
2012-01-01
Completion
2014-12-01
First posted
2010-12-21
Last updated
2015-06-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01263626. Inclusion in this directory is not an endorsement.

Cough Monitoring Study (NCT01263626) · Clinical Trials Directory